How Blasts Affect the Brain

Repeated exposure to explosions can damage the cerebellum in combat veterans and mouse models alike.

Written byAnna Azvolinsky
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The cerebellumWIKIMEDIA, JOHANNES SOBOTTAExplosions during military combat can initially cause mild traumatic brain injury (TBI), which may lead to later development of neurodegenerative disorders like chronic traumatic encephalopathy and Alzheimer’s disease. What happens when the brain is exposed to blasts has been studied in both military veterans and animal models, yet how blast exposure-related TBI pathologies are connected to the changes observed in neuroimaging studies has not been well understood. According to a study published today (January 13) in Science Translational Medicine, cumulative blast exposure is associated with pronounced alterations in veterans’ brains—notably in the cerebellum, a finding the authors recapitulated in mouse models.

“It can be hard to accurately gauge the amount of blast exposure that soldiers have experienced because that information is self-reported in retrospective designs like the current study,” said Justin Karr, a graduate student in clinical neuropsychology who studies TBI at the University of Victoria in British Columbia and was not involved in the work. “The novelty of this study is linking the veterans’ brain imaging to the pathology in the blast-exposed animal model.”

Even without direct hits from fragmented objects or the force of a head-on collision, prior work has shown that a sudden shock wave of increased atmospheric pressure—called blast overpressure—alone can injure the brain. Researchers at Seattle’s VA Puget Sound Health Care System and University of Washington first examined a cohort of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • head shot of blond woman wearing glasses

    Anna Azvolinsky received a PhD in molecular biology in November 2008 from Princeton University. Her graduate research focused on a genome-wide analyses of genomic integrity and DNA replication. She did a one-year post-doctoral fellowship at Memorial Sloan Kettering Cancer Center in New York City and then left academia to pursue science writing. She has been a freelance science writer since 2012, based in New York City.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies